0001140361-17-012580.txt : 20170317
0001140361-17-012580.hdr.sgml : 20170317
20170317164545
ACCESSION NUMBER: 0001140361-17-012580
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170317
DATE AS OF CHANGE: 20170317
EFFECTIVENESS DATE: 20170317
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOTRICITY INC.
CENTRAL INDEX KEY: 0001630113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 472548273
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-282869
FILM NUMBER: 17698609
BUSINESS ADDRESS:
STREET 1: 75 INTERNATIONAL BLVD., SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M9W 6L9
BUSINESS PHONE: (416) 214-3678
MAIL ADDRESS:
STREET 1: 75 INTERNATIONAL BLVD., SUITE 300
CITY: TORONTO
STATE: A6
ZIP: M9W 6L9
FORMER COMPANY:
FORMER CONFORMED NAME: METASOLUTIONS, INC.
DATE OF NAME CHANGE: 20150107
D
1
primary_doc.xml
X0707
D
LIVE
0001630113
BIOTRICITY INC.
275 Shoreline Drive
Suite 150
Redwood City
CA
CALIFORNIA
94065
(416) 214-3678
NEVADA
None
METASOLUTIONS, INC.
Corporation
true
2012
Waqaas
Al-Siddiq
275 Shoreline Drive
Suite 150
Redwood City
CA
CALIFORNIA
94065
Executive Officer
Director
CEO/Chairman
Biotechnology
No Revenues
- 06b
false
2017-03-07
false
true
true
false
50000
Corinthian Partners LLC
38912
None
None
850 Third Avenue
Suite 16C
New York
NY
NEW YORK
10022
FL
FLORIDA
OR
OREGON
WA
WASHINGTON
false
8000000
1232000
6768000
Option to increase by additional $12 million pursuant to overallotment.
false
0
100000
true
0
$100,000 assumes the minimum offering is sold. The placement agent will receive up to $800,000 if the maximum offering is sold (not including overallotment).
0
false
BIOTRICITY INC.
/s/ Waqaas Al-Siddiq
Waqaas Al-Siddiq
CEO/Chairman
2017-03-17